Clinical neurochemistry: Developments in dementia research based on brain bank material

Journal of Neural Transmission

Volumn 105, Issue 8-9, 1998, Pages 915-933

  Perry, E ^a   Court, J ^a   Goodchild, R ^a   Griffiths, M ^a   Jaros, E ^a   Johnson, M ^a   Lloyd, S ^a   Piggott, M ^a   Spurden, D ^a   Ballard, C ^a   McKeith, I ^a   Perry, R ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Dementia with Lewy bodies; Dopamine transporter and receptors; Histamine H2 receptor; Nicotinic receptor; Parkinson's disease

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HISTAMINE H2 RECEPTOR; HISTAMINE RECEPTOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NICOTINIC RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONSCIOUSNESS DISORDER; CORPUS STRIATUM; DEMENTIA; DOPAMINERGIC SYSTEM; GENETIC POLYMORPHISM; HALLUCINATION; HUMAN; HUMAN TISSUE; LEWY BODY; MEDICAL RESEARCH; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; SMOKING; THALAMUS;

BRAIN; DEMENTIA; HUMANS; NEUROCHEMISTRY; RESEARCH DESIGN; TISSUE BANKS;

EID: 7844222807     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050102     Document Type: Article

References (62)

1. Airaksinen MS, Paetau A, Paljarvi L, Reinikainen K, Riekkinen P, Suomalainen R, Panula P (1991) Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer's diseased brains. Neuroscience 44: 465-481
2. Albuquerque EX, Pereira EFR, Bonfante-Carbarcas R, Marchioro M, Matsubayashi H, Alkondon M, Maelicke A (1996) Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment - specific expression and modulatory control of channel activity. Prog Brain Res 109: 111-124
3. Alexander GM, Schwartzman RJ, Brainard L, Gordon SW, Grothusen (1992) Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys. Brain Res 588 (2): 261-269
4. Antonini A, Vontobel P, Psylla M, Gunther I, Maguire PR, Missimer J, Leenders KL (1995) Complementary positron emission tomographic studies of the striatal dopam-inergic system in Parkinson's disease. Arch Neurol 52: 1183-1190
5. Bentivoglio M, Steriade M (1990) Brainstem diencephalic circuits as a structural substrate of the ascending reticular activation concept. In: Marcia M, Marini G (eds) The diencephalon and sleep. Raven Press, New York, pp 7-29
6. Barbin G, Palacios JM, Garbarg M, Schwartz JC, Gaspar P, Javoy-Agid F, Agid Y (1980) L-Histidine decarboxylase in the human brain: properties and localization. J Neurochem 35: 400-406
7. Brandel JPA, Hirsch EC, Hersh LB, Javoy-Agid F (1990) Compartmental ordering of cholinergic innervation of the mediodorsal mucleus of the thalamus in human brain. Brain Res 515: 117-125
8. Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histatamine H2 blocking drugs. Neurobiol Aging 16: 523-530
9. Brezina V, Weiss KR (1997) Analysing the functional consequences of transmitter complexity. Trends Neurosci 20: 538-543
10. Court JA, Perry EK (1994) CNS nicotinic receptors: therapeutic target in neurodegeneration. CNS Drugs 2: 216-233
11. Court JA, Piggott MA, Perry EK, Barlow RB, Perry RH (1992) Age associated decline in high affinity nicotine binding in human brain frontal cortex does not correlate with the changes in choline acetyltransferase activity. Neurosci Res Commun 10: 125-133
12. Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJM, Piggott MA, Oakley AE, Ince PG, Scott DJ, Perry EK, Perry RH (1997) Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev Brain Res 101: 93-105
13. Cummings YL, Kaufer D (1996) Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 47: 876-883
14. Davis RE, Doyle PD, Carroll RT, Emmerling MR, Jaen J (1995) Cholinergic therapies for Alzheimer's disease - paliative or disease altering? Arzneimittelforschung 45: 425-431
15. Freedman R, Conn H, Myles-Worsley M, Orr-Urteger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkin J, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94: 587-592
16. 3H]Dopamine release from mouse striatal synaptosomes. J Neurochem 62: 1390-1398
17. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O (1989) The human doamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI, RFLP. Am J Hum Genet 45: 778-785
18. Harsing LG, Sershen H, Lajtha A (1992) Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitisation. J Neurochem 59: 48-54
19. Heckers S, Geula C, Mesulam MM (1992) Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J Comp Neurol 325: 68-82
20. Hobson JA (1992) Sleep and dreaming: induction and mediation of REM sleep by cholinergic mechanisms. Curr Opin Neurobiol 2: 759-763
21. Hobson JA, Lydie R, Baghdoyan HA (1986) Evolving concepts of sleep cycle generation - from brain centres to neuronal populations. Behav Brain Sci 9: 371-400
22. Hu B, Steriade M, Deschenes M (1989) The effects of brainstem peribrachial stimulation on perigeniculate neurons: the blockage of spindle waves. Neuroscience 31: 1-12
23. Joyce JN, Lexow N, Bird E, Winokur A (1988) Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2: 546-557
24. Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Weiland DM. Koeppe RA (1996) In vivo mapping of cholinergic terminals in normal aging. Alzheimer's disease and Parkinson's disease. Ann Neurol 40: 399-410
25. Ladner CJ, Celesia GG, Magnuson J, Lee JM (1995) Regional alterations in M1 muscarinic receptor - G protein coupling in Alzheimer's disease. J Neuropathol Exp Neurol 54: 783-789
26. 2 blocking drugs and the risk for Alzheimer's disease: the Rotterdam study. Neurobiol Aging 18: 257-259
27. Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Wagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R (1996) Nieotinic receptor function in schizophrenia. Schizophr Bull 22: 431-445
28. Levy R, Eagger S, Griffiths M, Perry E, Hanavar M, Dean A, Lantos P (1994) Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 343: 176
29. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G (1996) Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 109: 125-140
30. McCormick DA, Prince DA (1987) Actions of acetylcholine in the guinea pig and cat medial and lateral geniculate nuclei in vitro. J Physiol 392: 147-165
31. McKeith IG, Fairhairn AF, Perry RH, Thompson P, Perry EK (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 305: 673-678
32. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Dementia with Lewy bodies: diagnostic criteria and pathological guidelines. Report of the Consortium on Dementia with Lewy bodies. Neurology 47: 1113-1124
33. McEvoy JP, Lindgren J (1996) Smoking and schizophrenia. Drug Dev Res 38: 263-266
34. Manning KA, Wilson JR, Uhlrich DJ (1996) Histamine-immunoreactive neurones and their innervation of visual regions in the cortex, tectum and thalamus in the primate Macaca mulatta. J Comp Neurol 373: 271-282
35. 3) visualised in the brain of human and non-human primates. Brain Res 526: 322-327
36. Mirra SS, Hegman A, McKeel D, Sclerij SH, Crain BJ, Brownlee LM, Nogel FS, Hughes JP, van Beele G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD), part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-480
37. Nakamura S, Takemura M, Ohnishi K, Suenaga T, Nishimura M, Akiguchi I, Kimura J, Kimura T (1993) Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci Lett 151: 196-199
38. Nitsch RM, Growdon JH (1994) Role of neurotransmission in the regulation of amyloid-β-protein precursor processing. Biochem Pharmacol 47: 1275-1284
39. Ogawa N, Mizukawa K, Asanuma M, Kanazawa I (1993) Abnormalities in muscarinic cholinergic receptors and their G-protein coupling systems in the cerebral frontal cortex in Alzheimer's disease. Arch Gerontol Geriatr 17: 77-89
40. Parent A (1990) Extrinsic connections of the basal ganglia. Trends Neurosci 13: 254-258
41. Perry EK, Perry RH (1995) Acetylcholine and hallucinations: disease related compared to drug-induced alterations in human consciousness. Brain Cogn 28: 240-258
42. Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH (1990) Evidence of a monoaminergic: cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 55: 1454-1456
43. Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF (1990) Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 4 (2): 87-95
44. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Ince PG, Shaw PJ, Brown A, Perry RH (1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13: 393-400
45. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64: 385-395
46. Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF (1989) Senile dementia of Lewy body type and the spectrum of Lewy body disease. Lancet i: 1088
47. Perry RH, Irving D, Blessed G, Fairbairn AF, Perry EK (1990) Senile dementia of Lewy body type: a clinically and pathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119-139
48. Rogers SL, Friedhoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre randomized, doubleblind, placebo controlled trial. Dementia 7: 293-303
49. 3H]dopamine from rat striatal synaptosomes. Neurosci Lett 189: 171-175
50. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a Parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavioural disorder. Neurology 46: 388-393
51. Schneider C, Risser D, Kirchner L, Kitzmuller E, Cairns N, Prast H, Singewald N, Lubec G (1997) Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer's disease. Neurosci Lett 222: 183-186
52. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology 1 (1): 5-15
53. Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJM (1987) Guanine nucleotide modulation of muscarinic receptor binding in postmortem human brain - a preliminary study in Alzheimer's disease. Neurosci Lett 82: 227-232
54. 125T]α-bungarotoxin binding. J Chem Neuroanat 13: 105-113
55. Stevens KE, Waldo M, Freedman R (1996) Nicotinic receptor function in schizophrenia. Schizophr Bull 22: 431-445
56. 123I] IPT and single-photon emission tomography. Eur J Nucl Med 24 (4): 415-421
57. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA (1997) D2 dopamine receptor gene (DRD2) Taq 1 polymorphism reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7: 479-484
58. Traiffort E, Pollard H, Moreau J, Ruat M, Schwartz JC, Martinez-Mir MI, Palacios JM (1992) Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. J Neurochem 59: 290-299
59. Turner RS, Chervin RD, Frey KA, Minoshima S, Kuhl DE (1997) Probable diffuse Lewy body disease presenting as REM sleep behaviour disorder. Neurology 49: 523-527
60. Vehiyama M, Isse K, Tanaka K, Yakota N, Hamamoto M, Aida S, Ito Y, Yoshimura M, Okawa M (1995) Incidental Lewy body disease in a patient with REM sleep behaviour disorder. Neurology 45: 709-712
61. Warpman V, Alafuzoff I, Nordberg A (1993) Coupling of muscarinic receptors to GTP proteins in postmortem human brain - alterations in Alzheimer's disease. Neurosci Lett 150: 39-43
62. Xuereb JH, Perry RH, Candy JM, Bonham JR, Perry EK, Marshall E (1990) Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J Neurol Sci 99: 185-197